Thus CNP is a pivotal physiological stimulator of endochondral bone growth in humans and is now greatly anticipated to be a therapeutic reagent for the impaired skeletal growth observed in genetic disorders such as achondroplasia [13, 28, 29] or caused by drugs such as glucocorticoids [30, 31]. Here, CNP is linked to achondroplasia.